Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.6.4 was added to the record history and the previous v3.6.3 entry was removed, indicating an update to the page's release notes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedNew software revision v3.6.3 was added to the history. The previous revision v3.6.2 was removed, reflecting an internal update to the record's version-tracking system.SummaryDifference0.1%

- Check39 days agoChange DetectedThe record history shows the revision updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a newer platform release applied to the page. This update does not modify study data or visible content beyond the version label.SummaryDifference0.1%

- Check53 days agoChange DetectedNew actions 'Check who can join' and 'Find Contact Information' have been added to the history page, expanding access to enrollment criteria and study contact details. A new revision marker v3.6.0 appears, replacing the previous v3.5.5 entry.SummaryDifference0.6%

- Check60 days agoChange DetectedThe study record history shows a new revision entry (v3.5.5) that replaces the previous v3.5.4. This represents a minor update to the page's history metadata rather than changes to the trial data or study details.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision. This reflects a new release version for the study history page.SummaryDifference0.1%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.